RXRX Latest News

Here's Why Recursion Pharmaceuticals (RXRX) Fell More Than Broader Market

zacks.com — Apr 23, 2026

Recursion Pharmaceuticals (RXRX) reached $3. 5 at the closing of the latest trading day, reflecting a -6.

Recursion Pharmaceuticals, Inc. (RXRX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

seekingalpha.com — Apr 17, 2026

Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals (RXRX) Stock Drops Despite Market Gains: Important Facts to Note

zacks.com — Apr 16, 2026

Recursion Pharmaceuticals (RXRX) closed at $3. 6 in the latest trading session, marking a -4% move from the prior day.

Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors

zacks.com — Apr 9, 2026

Recursion Pharmaceuticals (RXRX) closed at $3. 32 in the latest trading session, marking a -2.

Recursion to Participate in Upcoming Investor Conferences

globenewswire.com — Apr 7, 2026

Salt Lake City, April 07, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical-stage TechBio company decoding biology to radically im